宮頸上皮脫落細(xì)胞mybl2 mRNA表達(dá)水平及意義
[Abstract]:Objective to investigate the relationship between the expression of mybl2 mRNA and the degree of cervical lesions and the infection of human papillomavirus (HPV) in exfoliated cells of cervical epithelium. Methods 232 cases of cervical epithelial exfoliated cells were collected and divided into two groups according to the results of liquid-based thin layer cell detection. 68 cases of atypical squamous cell (ASC-US) group and 98 cases of low grade squamous intraepithelial lesion group (LSIL) group) were divided into two groups: ASC-US group (n = 68) and (LSIL) group (n = 98). There were 42 cases of high squamous intraepithelial lesions (HSIL) and 24 cases of cervical cancer (SCC). The expression level of mybl2 mRNA was detected by Trizol total RNA,RT-PCR method, and the relationship between the expression of mybl2 mRNA and the degree of cervical lesions was analyzed, and the results of HPV detection were collected. The relationship between mybl2mRNA expression and HPV infection was analyzed. Results (1) the expression of mybl2 mRNA was detected in the exfoliated cells of cervical epithelium in 232 cases. There was significant difference in the expression of mybl2 mRNA in the exfoliated cells of cervical epithelium with different degree of lesion (FF68.491p0.01), and the expression level was positively correlated with the degree of cervical lesions. The expression level of mybl2 mRNA in exfoliated cells of SCC group was the highest. (2) the expression of mybl2 mRNA in exfoliated cells of cervix uteri was related to HPV infection, and the difference was statistically significant (FF12.15, P0.01), and the expression of HPV16 and / or HPV18 in exfoliated cells was the highest. Conclusion the expression of mybl2 mRNA in the exfoliated cells of cervical epithelium is positively correlated with the degree of cervical lesions and HPV infection. It may be related to the progression of cervical cancer and may be a new biomarker for the progression of cervical lesions.
【作者單位】: 清遠(yuǎn)市人民醫(yī)院檢驗(yàn)科;清遠(yuǎn)市人民醫(yī)院婦產(chǎn)科;
【基金】:清遠(yuǎn)市科技計(jì)劃項(xiàng)目(編號:2013B042)
【分類號】:R737.33
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 趙紅曄;杜樾;;宮頸癌297例臨床病理分析[J];中國社區(qū)醫(yī)師(醫(yī)學(xué)專業(yè)半月刊);2008年15期
2 徐艷紅;;宮頸癌的致病因素及預(yù)防的研究綜述[J];中國實(shí)用醫(yī)藥;2009年25期
3 畢建軍;楊慧蘭;;單純皰疹病毒2型與宮頸癌相關(guān)性的研究進(jìn)展[J];實(shí)用醫(yī)學(xué)雜志;2011年03期
4 孟斐;;組織因子途徑抑制物-2在宮頸癌中表達(dá)情況的研究分析[J];中國實(shí)用醫(yī)藥;2013年05期
5 劉威;高文霞;;宮頸癌患者組織及血清血管內(nèi)皮生長因子的變化研究[J];中國藥物經(jīng)濟(jì)學(xué);2013年04期
6 拉萊·蘇祖克;表皮生長因子受體和轉(zhuǎn)化生長因子-α在宮頸癌中的表達(dá)[J];診斷病理學(xué)雜志;2000年04期
7 許爭峰,胡婭莉,王迅美,戴魯琴,韓克,束澤寶;宮頸組織標(biāo)本中端粒酶活性檢測及臨床意義[J];江蘇醫(yī)藥;2001年05期
8 鄒紅燕,姚安梅,楊栓雀,趙西俠;青年宮頸癌相關(guān)因素分析[J];陜西腫瘤醫(yī)學(xué);2001年03期
9 小松;;宮頸癌已成女性殺手[J];中國醫(yī)藥指南;2004年03期
10 李隆玉,李誠信;宮頸癌的預(yù)防及普查[J];繼續(xù)醫(yī)學(xué)教育;2005年05期
相關(guān)會議論文 前10條
1 譚文福;吳緒峰;陳惠禎;;年輕宮頸癌的臨床特征及防治[A];全國子宮頸癌暨湖北省婦科腫瘤專業(yè)委員會第五次婦科腫瘤學(xué)術(shù)會議論文匯編[C];2006年
2 王勒渝;;宮頸Ⅰ號栓阻斷宮頸癌發(fā)生的組織病理學(xué)、超微結(jié)構(gòu)及免疫組織化學(xué)的研究[A];第八屆全國中西醫(yī)結(jié)合腫瘤學(xué)術(shù)會議論文集[C];2000年
3 段微;;超高頻無線電波刀治療宮頸癌前病變的研究[A];2000全國腫瘤學(xué)術(shù)大會論文集[C];2000年
4 黃妙玲;陳R,
本文編號:2290813
本文鏈接:http://sikaile.net/yixuelunwen/fuchankeerkelunwen/2290813.html